“Based on the literature that I have read, with the more advanced and the more recent testing…the goal is to increase the efficacy of the test,” said David C. Collymore, MD, MBA. With the rapid developments seen in recent years, Collymore highlights several advantages of the newer generation tests. He thinks these tests are less expensive, they have a much faster turnaround time, and the newer tests can analyze a much bigger sample size over a much shorter duration of time. “I think those are tremendous advances in terms of making the tests more accessible to the general population,” Collymore said.
Not being familiar with the very latest developments in the field of diagnostic testing, Collymore said he cannot predict what the cutting edge developments will be in the space, “But I do know that the advances that have been made are very positive.” Indicating the need to conduct a significant number of studies that yield little or any benefit in order to get to that one study that will demonstrate significant change, he said, “Recent research has been very positive, has been able to yield greater results, and has made testing available to the general population.”
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Following Roe v Wade Overturn, Research Focuses on Male Contraceptives
May 6th 2024Stephanie T. Page, MD, PhD, UW Medicine Diabetes Institute, presented on ongoing research and growing interest in new male contraceptive options, such as an oral pill and a hormonal transdermal gel, at the American Urological Association 2024 Annual Meeting.
Read More